Although initially activated to buffer metabolic stress, the PINK1-Parkin pathway becomes suppressed under chronic overload, such as prolonged palmitate exposure, resulting in dysfunctional mitochondria, heightened oxidative stress, and activation of the NLRP3 inflammasome
A groundbreaking study from the University of Chicago demonstrated that just three nights of insufficient sleep could lead to a 30% reduction in insulin sensitivity
The regulatory environment for compounded GLP-1 medications is actively evolving
Whether using an IV drip for skin glow or oral antioxidant supplements, the goal is similar: improve radiance safely
GLP-1 medications trigger the bodys GLP-1 receptor, which increases insulin production, decreases glucagon release (another hormone that elevates blood sugar), slows gastric emptying (the pace at which food leaves the stomach), and intensifies sensations of fullness